Monday announced that nine provinces have approved accelerated public coverage of Epkinly, a treatment for adult ...
AbbVie (NYSE: ABBV) today announced that nine provinces have provided accelerated public coverage of EPKINLYâ„¢. EPKINLY is a treatment for adult patients with Relapsed or Refractory diffuse large ...
AbbVie (NYSE: ABBV), today announced that nine (9) provinces have provided accelerated public coverage of EPKINLYâ„¢. EPKINLY is a treatment for adult patients with Relapsed or Refractory diffuse large ...